Navigation Links
Success for Crystal Meth Drug Addict on YouTube
Date:6/19/2008

TROIS-RIVIERES, Quebec, June 19 /PRNewswire/ -- According to Narconon Trois-Rivieres, crystal methamphetamine (more commonly referred to as crystal meth) is a drug known to cause severe addiction problems. The side effects associated with crystal meth consumption are blatantly devastating: the shakiness, the paranoia, the agitation and insomnia lasting for days all weigh heavily on the drug user. Meth is still a drug of choice for many since it is easily available to anyone and cheaper than numerous other drugs.

Health officials nationwide express growing concern over whether crystal meth addicts may ever be capable of breaking free of this life-damaging habit. Effective and successful drug treatments are scarce, and too many times they are incapable of meeting the demand. According to addiction counselors, the relapse rate for crystal meth abusers who entered traditional drug rehabilitation treatment in 2006 is drastically worse than cocaine at 92%.

Will Opitz, a former crystal meth addict of 3 years, had lost all threads of rational thoughts and yielded his self-control to his cravings: "Four days later [after taking crystal meth] I was still partying. This was at the beginning of December 1999. By the end of December I had lost 50 pounds because I ate maybe once or twice that whole month."

In this interview, Will explains how his life was radically changed by Narconon, a 100% drug-free drug rehabilitation center, after all the hardships and crushing failures he had faced: " ... If it wasn't for the staff here, seeing the good and the potential in me, I'd probably be dead right now ... ."

Eager to share his accomplishment of kicking crystal meth, Will tells his story in a video entitled "Dying Addict Finds Crystal Meth Treatment." The success of this video has been beyond expectations with over 118,000 views on the broadcasting site YouTube.

The effectiveness of the Narconon(R) drug rehabilitation program is reflected on a
'/>"/>

SOURCE Narconon Trois-Rivieres
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine news :

1. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
2. Birds communicate reproductive success in song
3. LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful
4. Better Sleepers Are Successful Agers
5. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
6. Normal sleep linked to successful aging
7. Inspired by Diabetes U.S. National Contest Winners Share Stories of Perseverance and Success in Managing Diabetes
8. Redefining a Products Identity Key to a Successful Re-Launch
9. GCI Successfully Transitions All Traffic to Galaxy 18 Satellite
10. Sen. Kennedys Brain Tumor Surgery Called a Success
11. Staying sharp in Phoenix: Leading brain experts discuss successful aging
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Coast Dental Deploys Demandforce D3 Communications Platform 56970 1Coast Dental Deploys Demandforce D3 Communications Platform 56970 2Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 1Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 2Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 3Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 1Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 2